Evidence map›Paper›PMID 41540067›Full record

ArticleNature communications2026

Tmem110 regulates the conformation of TRPML1 to maintain endolysosomal homeostasis and prevent mitochondrial DNA leakage and pathological self-DNA processing.

Zunyong Feng, Yuanbo Pan, Jing Zhou, Liuxi Chu, Qiang Li, Xuanbo Zhang, Ping Wu, Zhiliang Xu, Yanjiao Huang, Jianhua Zou and 3 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Zunyong Feng *State Key Laboratory of Macromolecular Drugs and Large-scale Preparation, School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, China. fengzy@wmu.edu.cn.ORCID http://orcid.org/0000-0001-5048-5796
Yuanbo Pan *Department of Neurosurgery, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Jing Zhou *State Key Laboratory of Macromolecular Drugs and Large-scale Preparation, School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, China.
Liuxi Chu *The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Qiang LiHuman Anatomy Experimental Training Center, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Wannan Medical College, Wuhu, Anhui, China.
Xuanbo ZhangDepartment of Diagnostic Radiology, Yong Loo Lin School of Medicine; Department of Chemical and Biomolecular Engineering, College of Design and Engineering; Department of Biomedical Engineering, College of Design and Engineering; Department of Pharmacy and Pharmaceutical Sciences, Faculty of Science; Clinical Imaging Research Centre, Centre for Translational Medicine, Yong Loo Lin School of Medicine; Nanomedicine Translational Research Program, Yong Loo Lin School of Medicine; Theranostics Center of Excellence (TCE), Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Ping WuState Key Laboratory of Macromolecular Drugs and Large-scale Preparation, School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, China.
Zhiliang XuHuman Anatomy Experimental Training Center, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Wannan Medical College, Wuhu, Anhui, China.
Yanjiao HuangHuman Anatomy Experimental Training Center, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Wannan Medical College, Wuhu, Anhui, China.
Jianhua ZouDepartment of Diagnostic Radiology, Yong Loo Lin School of Medicine; Department of Chemical and Biomolecular Engineering, College of Design and Engineering; Department of Biomedical Engineering, College of Design and Engineering; Department of Pharmacy and Pharmaceutical Sciences, Faculty of Science; Clinical Imaging Research Centre, Centre for Translational Medicine, Yong Loo Lin School of Medicine; Nanomedicine Translational Research Program, Yong Loo Lin School of Medicine; Theranostics Center of Excellence (TCE), Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.ORCID http://orcid.org/0000-0003-0718-9128
Xiaokun LiState Key Laboratory of Macromolecular Drugs and Large-scale Preparation, School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, China. xiaokunli@wmu.edu.cn.ORCID http://orcid.org/0000-0002-6556-6262
Xiaoyuan ChenDepartment of Diagnostic Radiology, Yong Loo Lin School of Medicine; Department of Chemical and Biomolecular Engineering, College of Design and Engineering; Department of Biomedical Engineering, College of Design and Engineering; Department of Pharmacy and Pharmaceutical Sciences, Faculty of Science; Clinical Imaging Research Centre, Centre for Translational Medicine, Yong Loo Lin School of Medicine; Nanomedicine Translational Research Program, Yong Loo Lin School of Medicine; Theranostics Center of Excellence (TCE), Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. chen9647@gmail.com.ORCID http://orcid.org/0000-0002-9622-0870
Zhouguang WangThe First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China. wangzhouguang@wmu.edu.cn.ORCID http://orcid.org/0000-0001-9903-0362

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The mechanisms by which phagocytes handle large quantities of internalized organelles, such as mitochondria released during tissue injury, remain unclear. Here we show that the endoplasmic reticulum transmembrane regulator TMEM110 is a key determinant of disease severity in traumatic brain injury-associated multiple organ dysfunction. Loss of TMEM110 impairs the clearance of mitochondria aberrantly released into the circulation, leading to heightened autoimmune-mediated tissue injury and mortality. TMEM110 maintains lysosomal function by controlling the conformational transition of the lysosomal ion channel TRPML1 and generating localized calcium efflux sites, thereby preventing calcium overload, membrane disruption, and leakage of mitochondrial DNA into the cytosol. We further find that TMEM110 expression is restrained by the nucleic acid sensor STING under basal conditions, and that a naturally occurring interface mutation between TMEM110 and STING causes defective lysosomal DNA disposal and aberrant type I interferon activity. These findings identify a feedback pathway linking cytosolic DNA sensing to organelle homeostasis.

Indexed as

DNA, MitochondrialLysosomesMembrane ProteinsPhagocytesTransient Receptor Potential ChannelsAdultAnimalsBrain Injuries, TraumaticCalciumCytosolDisease Models, AnimalEndocytosisEndoplasmic ReticulumFemaleHomeostasisHumansCalciumDNA, MitochondrialInterferon Type IMCOLN1 protein, humanMembrane ProteinsSTIMATE protein, humanSTING ProteinTransient Receptor Potential Channels

Identifiers

PMID41540067
PMCPMC12910075

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.